Hunan Cancer Hospital ( Site 0094)

Changsha, Hunan 410006

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Hepatocellular

Studies at this site

• Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002) — Completed